Skip to main content
. 2020 Jan 21;13:161–174. doi: 10.2147/DMSO.S233538

Figure 1.

Figure 1

Potential mechanisms for the cardio-/nephroprotective effects of SGLT2i. The effects observed in large clinical trials are shown in the green box, those resulted from studies with a small number of patients or in animal models are shown in the red box.